MedPath

Feasibility of Bright Light Therapy on Fatigue, Sleep and Circadian Activity Rhythms in Lung Cancer Survivors

Not Applicable
Completed
Conditions
Fatigue
Sleep Disturbance
Circadian Dysregulation
Registration Number
NCT02954809
Lead Sponsor
State University of New York at Buffalo
Brief Summary

The purpose of this study is to determine the feasibility of a morning bright light therapy intervention for fatigue, sleep disturbances, and circadian activity rhythms in lung cancer survivors.

Detailed Description

A randomized controlled trial to test the effects of morning bright light therapy on fatigue, sleep disturbances, and circadian activity rhythms in lung cancer survivors.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
14
Inclusion Criteria
  • Stage I-III Non-small cell lung cancer survivors
  • Must be at >6-weeks and < 3 years post-surgical resection
  • Must have diagnosis fatigue and/or sleep disturbances
Exclusion Criteria
  • Individuals clinically unstable.
  • Mania, Bipolar disease or seizure disorder
  • Macular degeneration or glaucoma.
  • Currently receiving chemotherapy or radiation.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Study CompletionBaseline

The percentage of participants recruited that completed the study

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

SUNY University at Buffalo

🇺🇸

Buffalo, New York, United States

SUNY University at Buffalo
🇺🇸Buffalo, New York, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.